Division of Biomedical Technology544
Division of Biomedical Technology aims to improve quality of human life through the convergence of basic, applied life science and biomaterial technology development. We will conduct research on disease-related mechanisms and therapeutic targets based on the companion indicators, and develop molecular and non-molecular diagnostic indicators including drug-susceptibility. Functional biomaterials and bioplastics using biocompatible polymers are under development and a variety of microplastic models are studied to test its ecological and human health hazards. We aim to contribute to the improvement of national health and quality of life as part of the national science and technology policy related to biomedical research.
DGIST Division of Biomedical Technology Homepage
DGIST Division of Biomedical Technology Homepage
Subject
- Phase Transition 1
- PHASE-FIELD MODEL 1
- PHASE-I 1
- PHASE-II 1
- PHASE-SEPARATION 1
- PHBV 1
- PHENOL 1
- Phenols 1
- PHENOTYPE 1
- Phorbol Ester 1
Date issued
- 2020 - 2026 182
- 2010 - 2019 182
- 2006 - 2009 24
Co-Author(s)
Related Keyword
Recent Submissions
- A Steerable and Expandable Magnetic Aspiration Catheter for Enhanced Aspiration Thrombectomy
- Magnetic Control of Intravascular Collaborative Robotic (Cobot) Guidewire: Neurovascular Intervention Studies in Phantom and Swine Models
- 척수를 위한 광학 센서 거치 장치 및 방법
- 96-Well Format-Based Liver–Heart-on-a-Chip Platform for Facile and Parallel Testing of Drug-Induced Cardiotoxicity after Liver Metabolism
- Polystyrene Nanoplastics Exacerbate CCl4-Induced Liver Fibrosis by Aggravating Stretch-Induced Mechanical Stress in Hepatic Stellate Cells
